Drug Profile
LLL 2011
Alternative Names: Amigra; LL-2011; LLL-2011Latest Information Update: 08 Sep 2016
Price :
$50
*
At a glance
- Originator Lupin
- Class Antimigraines; Phytotherapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 07 Sep 2010 Lupin completes enrolment in its phase III trial for migraine in India
- 13 Aug 2010 Phase-III development is ongoing in India
- 02 Oct 2009 Phase III development is ongoing In India